
Jean Lopategui, MD, discusses the evolution of targeted therapies in non–small cell lung cancer.

Your AI-Trained Oncology Knowledge Connection!


Jean Lopategui, MD, discusses the evolution of targeted therapies in non–small cell lung cancer.

Jean Lopategui, MD, discusses the evolution of molecular testing in non–small cell lung cancer.

Jean Lopategui, MD, associate professor of pathology and director of Translational Genomics and of the Molecular Genetics Pathology Fellowship at Cedars-Sinai, discusses the implications of genomic sequencing in lung cancer.

Jean Lopategui, MD, discusses the use of liquid biopsies in lung cancer.

Published: February 21st 2020 | Updated:

Published: March 4th 2020 | Updated:

Published: May 5th 2020 | Updated:

Published: June 5th 2020 | Updated: